- Recent Funding
- Investors
- 3E Bioventures
3E Bioventures portfolio
3E Bioventures has 2 portfolio companies on record at Recent Funding.
About this page
Its most recent investment on record is OncoC4's $50M Series B+ round in October 2025, alongside HM Capital, Kaitai Capital and GBA Fund. By category, its portfolio leans toward Health and bio (2).
What 3E Bioventures invests in
- Health and bio · 2 · 100%
How 3E Bioventures invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $50M |
3E Bioventures portfolio companies
OOncoC4$50MSeries B+ · Oct 2025
AArnatar Therapeuticsbacker
| Company | Round with 3E Bioventures | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $50M | $50M | Oct 2, 2025 Series B+ |
Health and bio |
backer | $102M | Mar 14, 2026 Series A |
Most frequent co-investors
KKaitai Capital1 shared round · last Oct 2, 2025
HHM Capital1 shared round · last Oct 2, 2025
- GGBA Fund1 shared round · last Oct 2, 2025
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name 3E Bioventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists 3E Bioventures, which is a subset of its real portfolio. API: /api/v1/investors/3e-bioventures (get a free API key). More: the most active VC firms and new venture capital funds.